Activated N-ras controls the transformed phenotype of HT1080 human fibrosarcoma cells
- PMID: 3315232
- DOI: 10.1016/0092-8674(87)90103-6
Activated N-ras controls the transformed phenotype of HT1080 human fibrosarcoma cells
Abstract
To investigate whether the activated N-ras oncogene of HT1080 human fibrosarcoma cells contributes to the expression of the transformed phenotype, we have isolated flat revertants. In two independent revertant lines, an increase in chromosomal ploidy occurred without a concomitant increase in the number of copies of the N-ras transforming allele. Immunoprecipitation confirms that the level of the mutant N-ras p21 gene product in the revertants is correspondingly lower than in HT1080. Analysis of sporadic tumors derived from the revertant cells reveals an increased dosage of the transforming allele. The revertants also retransform after transfection of cloned activated ras oncogenes. These results imply direct participation of an N-ras oncogene in maintaining the transformed phenotype of a human tumor cell line.
Similar articles
-
Flat revertants of EJ human bladder carcinoma cells show two different mechanisms of reversion.Ciba Found Symp. 1989;142:134-43; discussion 143-8. doi: 10.1002/9780470513750.ch9. Ciba Found Symp. 1989. PMID: 2663383
-
N-ras dependent revertant phenotype in human HT1080 fibrosarcoma cells is associated with loss of proliferation within normal tissues and expression of an adult membrane antigenic phenotype.Oncogene. 1989 Jul;4(7):873-80. Oncogene. 1989. PMID: 2666908
-
Differential contribution of the ERK and JNK mitogen-activated protein kinase cascades to Ras transformation of HT1080 fibrosarcoma and DLD-1 colon carcinoma cells.Oncogene. 1999 Mar 11;18(10):1807-17. doi: 10.1038/sj.onc.1202482. Oncogene. 1999. PMID: 10086335
-
Defining the mechanisms of transformation through analysis of revertant cells.Immunol Ser. 1990;51:15-47. Immunol Ser. 1990. PMID: 2095917 Review. No abstract available.
-
The p53 tumor suppressor gene and gene product.Princess Takamatsu Symp. 1989;20:221-30. Princess Takamatsu Symp. 1989. PMID: 2488233 Review.
Cited by
-
Activation of anchorage-independent growth of HT1080 human fibrosarcoma cells by dexamethasone.In Vitro Cell Dev Biol Anim. 2002 Feb;38(2):111-7. doi: 10.1290/1071-2690(2002)038<0111:AOAIGO>2.0.CO;2. In Vitro Cell Dev Biol Anim. 2002. PMID: 11928993
-
A novel cell-based assay for the evaluation of anti-ras compounds.Br J Cancer. 1993 Nov;68(5):856-61. doi: 10.1038/bjc.1993.445. Br J Cancer. 1993. PMID: 8217601 Free PMC article.
-
KRAS codon 12 mutations occur very frequently in pancreatic adenocarcinomas.Nucleic Acids Res. 1988 Aug 25;16(16):7773-82. doi: 10.1093/nar/16.16.7773. Nucleic Acids Res. 1988. PMID: 3047672 Free PMC article.
-
Tumor cell invasion of collagen matrices requires coordinate lipid agonist-induced G-protein and membrane-type matrix metalloproteinase-1-dependent signaling.Mol Cancer. 2006 Dec 8;5:69. doi: 10.1186/1476-4598-5-69. Mol Cancer. 2006. PMID: 17156449 Free PMC article.
-
Down-regulation of caveolin-1, a candidate tumor suppressor gene, in sarcomas.Am J Pathol. 2001 Mar;158(3):833-9. doi: 10.1016/S0002-9440(10)64031-X. Am J Pathol. 2001. PMID: 11238032 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous